Pathophysiology of prediabetes

[1]  Ralph A. DeFronzo,et al.  From the Triumvirate to the Ominous Octet: A New Paradigm for the Treatment of Type 2 Diabetes Mellitus , 2009, Diabetes.

[2]  Claudio Cobelli,et al.  Primary Defects in β-Cell Function Further Exacerbated by Worsening of Insulin Resistance Mark the Development of Impaired Glucose Tolerance in Obese Adolescents , 2009, Diabetes Care.

[3]  R. DeFronzo,et al.  Strong association between insulin resistance in liver and skeletal muscle in non‐diabetic subjects , 2008, Diabetic medicine : a journal of the British Diabetic Association.

[4]  M. Matsuda,et al.  The relationship between fasting hyperglycemia and insulin secretion in subjects with normal or impaired glucose tolerance. , 2008, American journal of physiology. Endocrinology and metabolism.

[5]  S. Caprio,et al.  Metabolic abnormalities underlying the different prediabetic phenotypes in obese adolescents. , 2008, The Journal of clinical endocrinology and metabolism.

[6]  S. Caprio,et al.  Prediabetes and type 2 diabetes in youth: an emerging epidemic disease? , 2008, Current opinion in endocrinology, diabetes, and obesity.

[7]  R. DeFronzo,et al.  Adipocytes in subjects with impaired fasting glucose and impaired glucose tolerance are resistant to the anti-lipolytic effect of insulin , 2008, Acta Diabetologica.

[8]  T. Hansen,et al.  Insulin sensitivity, insulin release and glucagon-like peptide-1 levels in persons with impaired fasting glucose and/or impaired glucose tolerance in the EUGENE2 study , 2008, Diabetologia.

[9]  B. Zinman,et al.  Impaired Fasting Glucose and Impaired Glucose Tolerance , 2007, Diabetes Care.

[10]  S. Yusuf,et al.  The DREAM trial – Authors' reply , 2006, The Lancet.

[11]  R. DeFronzo,et al.  Insulin resistance and endothelial dysfunction: the road map to cardiovascular diseases , 2006, Diabetes/metabolism research and reviews.

[12]  M. Laakso,et al.  Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial , 2006, The Lancet.

[13]  R. DeFronzo.  Is insulin resistance atherogenic? Possible mechanisms. , 2006, Atherosclerosis. Supplements.

[14]  H. Woerle,et al.  Different Mechanisms for Impaired Fasting Glucose and Impaired Postprandial Glucose Tolerance in Humans A table elsewhere in this issue shows conventional and Système International (SI) units and conversion factors for many substances. , 2006, Diabetes Care.

[15]  R. DeFronzo,et al.  Contributions of β-Cell Dysfunction and Insulin Resistance to the Pathogenesis of Impaired Glucose Tolerance and Impaired Fasting Glucose A table elsewhere in this issue shows conventional and Système International (SI) units and conversion factors for many substances. , 2006, Diabetes Care.

[16]  R. DeFronzo,et al.  Insulin Secretion and Action in Subjects With Impaired Fasting Glucose and Impaired Glucose Tolerance , 2006, Diabetes.

[17]  M. Abdul-Ghani,et al.  Different contributions of insulin resistance and beta‐cell dysfunction in overweight Israeli Arabs with IFG and IGT , 2006, Diabetes/metabolism research and reviews.

[18]  N. Gungor,et al.  Type 2 diabetes mellitus in youth: the complete picture to date. , 2005, Pediatric clinics of North America.

[19]  M. Engelgau,et al.  Prevalence of Impaired Fasting Glucose and Its Relationship With Cardiovascular Disease Risk Factors in US Adolescents, 1999–2000 , 2005, Pediatrics.

[20]  S. Fowler,et al.  Intensive lifestyle intervention or metformin on inflammation and coagulation in participants with impaired glucose tolerance. , 2005, Diabetes.

[21]  S. Fowler,et al.  Prevention of type 2 diabetes with troglitazone in the Diabetes Prevention Program. , 2005, Diabetes.

[22]  W. Tamborlane,et al.  Predictors of changes in glucose tolerance status in obese youth. , 2005, Diabetes care.

[23]  Masafumi Matsuda,et al.  beta-Cell function in subjects spanning the range from normal glucose tolerance to overt diabetes: a new analysis. , 2005, The Journal of clinical endocrinology and metabolism.

[24]  R. DeFronzo.  Dysfunctional fat cells, lipotoxicity and type 2 diabetes , 2004, International journal of clinical practice. Supplement.

[25]  A. Karter,et al.  Differences in insulin resistance in nondiabetic subjects with isolated impaired glucose tolerance or isolated impaired fasting glucose. , 2004, Diabetes.

[26]  H. Kuroki,et al.  Who are more insulin resistant, people with IFG or people with IGT? , 2004, Diabetologia.

[27]  S. Genuth.  Lowering the criterion for impaired fasting glucose is in order. , 2003, Diabetes care.

[28]  M. Davidson,et al.  Lowering the criterion for impaired fasting glucose will not provide clinical benefit. , 2003, Diabetes care.

[29]  J. Shaw,et al.  Follow-up report on the diagnosis of diabetes mellitus. , 2003, Diabetes care.

[30]  J. Tuomilehto,et al.  Predictive properties of impaired glucose tolerance for cardiovascular risk are not explained by the development of overt diabetes during follow-up. , 2003, Diabetes care.

[31]  W. Dietz,et al.  Prevalence of a metabolic syndrome phenotype in adolescents: findings from the third National Health and Nutrition Examination Survey, 1988-1994. , 2003, Archives of pediatrics & adolescent medicine.

[32]  Beverley Balkau,et al.  Age- and sex-specific prevalence of diabetes and impaired glucose regulation in 11 Asian cohorts. , 2003, Diabetes care.

[33]  S. Teutsch,et al.  NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older. , 2003, Diabetes.

[34]  S. Kahn,et al.  The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes , 2003, Diabetologia.

[35]  M. Matsuda,et al.  Beta-cell dysfunction and glucose intolerance: results from the San Antonio metabolism (SAM) study , 2003, Diabetologia.

[36]  G. Gallus,et al.  Age- and sex-specific prevalences of diabetes and impaired glucose regulation in 13 European cohorts. , 2003, Diabetes care.

[37]  J. Gerich,et al.  Brazilian individuals with impaired glucose tolerance are characterized by impaired insulin secretion. , 2002, Diabetes & metabolism.

[38]  K. Choi,et al.  Comparison of ADA and WHO criteria for the diagnosis of diabetes in elderly Koreans , 2002, Diabetic medicine : a journal of the British Diabetic Association.

[39]  J. Shaw,et al.  Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention , 2002, Diabetic medicine : a journal of the British Diabetic Association.

[40]  Robert Atkins,et al.  The rising prevalence of diabetes and impaired glucose tolerance: the Australian Diabetes, Obesity and Lifestyle Study. , 2002, Diabetes care.

[41]  S. Fowler,et al.  Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. , 2002 .

[42]  T. W. Haeften,et al.  Disturbances in β-Cell Function in Impaired Fasting Glycemia , 2002 .

[43]  S. Saydah,et al.  Postchallenge hyperglycemia and mortality in a national sample of U.S. adults. , 2001, Diabetes care.

[44]  T. Valle,et al.  Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. , 2001, The New England journal of medicine.

[45]  E. Feskens,et al.  Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria. , 2001, Archives of internal medicine.

[46]  J. Tuomilehto,et al.  Comparison of the fasting and the 2-h glucose criteria for diabetes in different Asian cohorts , 2000, Diabetologia.

[47]  R. Hanson,et al.  The 1997 American Diabetes Association and 1999 World Health Organization criteria for hyperglycemia in the diagnosis and prediction of diabetes. , 2000, Diabetes care.

[48]  C. Bogardus,et al.  Metabolic characteristics of individuals with impaired fasting glucose and/or impaired glucose tolerance. , 1999, Diabetes.

[49]  P. Savage,et al.  Cardiovascular disease in older adults with glucose disorders: comparison of American Diabetes Association criteria for diabetes mellitus with WHO criteria , 1999, The Lancet.

[50]  J Tuomilehto,et al.  Impaired fasting glucose or impaired glucose tolerance. What best predicts future diabetes in Mauritius? , 1999, Diabetes care.

[51]  S. Yusuf,et al.  The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years. , 1999, Diabetes care.

[52]  J. Chan,et al.  Use of the 1997 American Diabetes Association Diagnostic Criteria for Diabetes in a Hong Kong Chinese Population , 1998, Diabetes Care.

[53]  L. Bouter,et al.  The 1997 American Diabetes Association Criteria Versus the 1985 World Health Organization Criteria for the Diagnosis of Abnormal Glucose Tolerance: Poor agreement in the Hoorn Study , 1998, Diabetes Care.

[54]  G. Berglund,et al.  Comparison of ADA and WHO criteria for diagnosis of diabetes and glucose intolerance , 1998, Diabetologia.

[55]  B. Ahrén,et al.  Glucose-dependent arginine stimulation test for characterization of islet function: studies on reproducibility and priming effect of arginine , 1998, Diabetologia.

[56]  K. Flegal,et al.  Comparison of Diabetes Diagnostic Categories in the U.S. Population According to 1997 American Diabetes Association and 1980–1985 World Health Organization Diagnostic Criteria , 1997, Diabetes Care.

[57]  R. DeFronzo.  Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidaemia and atherosclerosis. , 1997, The Netherlands journal of medicine.

[58]  D. Schuster,et al.  Pathogenetic Mechanisms of Impaired Glucose Tolerance and Type II Diabetes in African-Americans: The significance of insulin secretion, insulin sensitivity, and glucose effectiveness , 1997, Diabetes Care.

[59]  L. Groop,et al.  Glucose and free fatty acid metabolism in non-insulin-dependent diabetes mellitus. Evidence for multiple sites of insulin resistance. , 1989, The Journal of clinical investigation.

[60]  G. Reaven.  Role of Insulin Resistance in Human Disease , 1988, Diabetes.

[61]  Yii-Der I. Chen,et al.  Measurement of Plasma Glucose, Free Fatty Acid, Lactate, and Insulin for 24 h in Patients With NIDDM , 1988, Diabetes.